Noile-Immune Biotech, Inc.

36
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3759560000
JPY
142.00
-1 (-0.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Noile-Immune Biotech, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-962.00
-1,127.00
-384.00
-792.00
-630.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
76.00
-95.00
0.00
-9.00
134.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-887.00
-873.00
-107.00
-777.00
-300.00
Cash Flow from Investing Activities
0.00
-5.00
0.00
-4.00
0.00
Cash Flow from Financing Activities
2.00
1,913.00
487.00
2,373.00
996.00
Net Cash Inflow / Outflow
-884.00
1,034.00
380.00
1,592.00
695.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Noile-Immune Biotech, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-962.035
4368.056
-5,330.00
-122.02%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
76.674
151.804
-75.00
-49.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-887.809
3830.664
-4,717.00
-123.18%
Cash Flow from Investing Activities
0.557
-1471.124
1,471.00
100.04%
Cash Flow from Financing Activities
2.5
795.246
-793.00
-99.69%
Net Cash Inflow / Outflow
-884.752
3159.868
-4,043.00
-128.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
5.082
-5.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -1.69% vs -714.62% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-887.81
-873.08
-1.69%